Los Angeles, May 2 -- The U.S. Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) on Thursday announced the launch of Generation Gold Standard, a next-generation universal vaccine platform designed to combat pandemic-prone viruses.
The platform is based on a beta-propiolactone (BPL)-inactivated, whole-virus approach - a modernized take on traditional vaccine technology, according to the NIH.
This initiative represents a decisive shift toward transparency, effectiveness, and comprehensive preparedness, funding the NIH's in-house development of universal influenza and coronavirus vaccines, including candidates BPL-1357 and BPL-24910, said the NIH in a release.
These vaccines aim to provide broad-s...